As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

HHS underwent a sweeping restructuring this week, resulting in about 10,000 layoffs across various agencies. With critical programs for things like disease prevention and outbreak response already ...

All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA ...

Now that AI tools are everywhere, the question making headlines is whether businesses will see substantial returns from their AI investments. The answer for health plans is a definite yes.

Virtual and hybrid therapy companies are expanding rapidly amid persistently high demand levels for mental health services. On Tuesday, mental health care provider SonderMind participated in this ...

In recent years, hospital breaches have dominated headlines and board-level discussions, shining a harsh light on cybersecurity and privacy vulnerabilities within clinical settings. Ransomware ...

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is a rare autoimmune disorder characterized by necrotizing vasculitis of small-to medium-sized blood ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications ...

The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...